An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease
Completed
Boehringer Ingelheim
Phase 3
1969-12-31
To provide access to Viramune and to evaluate the tolerance and safety of Viramune in
patients with progressive, symptomatic HIV disease who failed or are intolerant to currently
approved treatment for HIV-1 infection and who are unable to participate in another Viramune
controlled clinical trial and have a compelling need for anti-HIV treatment.
An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.
Completed
Boehringer Ingelheim
Phase 1
1969-12-31
To evaluate the potential pharmacokinetic interaction between nevirapine and clarithromycin,
and to determine the effects of nevirapine on cytochrome P450 3A4 (CYP3A4) activity in vivo.
The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs
Completed
Boehringer Ingelheim
Phase 3
1969-12-31
To evaluate the tolerance, safety, and effectiveness of Viramune in preventing clinical AIDS
progression events or death when used in combination with Lamivudine and background
nucleoside therapy.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
